Anemia Prevalence among Mexican Patients with CKD
Kidney Week 2020
Patients with chronic kidney disease (CKD) often experience anemia, a condition commonly associated with physical disability, decreased cognitive function, and poor quality...
Comorbidities in Patients with CKD Across KDIGO Stages
Kidney Week 2020
Chronic kidney disease (CKD) is a leading public health problem worldwide. At present, only estimates based on records of patients with advanced...
Dr. Tony Lin Summarizes Venclexta Data Presented at ASH
The all-virtual 62nd ASH Annual Meeting & Exposition highlighted some of the newest data about Venclexta. DocWire News interviewed Tony Lin, Pharm.D., a Senior...
LUMMICAR-2: CT053 BCMA CAR T Is Active in Refractory Myeloma, But Toxicity Persists
The novel chimeric antigen receptor (CAR) T cell therapy, CT053, achieved a 100% overall response rate (ORR) for the treatment of relapsed/refractory multiple myeloma...
Oral Iron Therapy in Pediatric CKD Patients
Kidney Week 2020
Patients with chronic kidney disease (CKD) commonly develop anemia. Current guidelines recommend oral iron therapy as first-line treatment for anemia. According to...
Prevalence of Anemia in Patients with Non-Dialysis Dependent CKD
Kidney Week 2020
Anemia in patients with chronic kidney disease (CKD) is associated with erythropoietin deficiency and resistance, and a heightened inflammatory state. Treatment with...
Roxadustat Efficacious and Safe in Non-Dialysis-Dependent CKD Patients with Anemia
Kidney Week 2020
Researchers in Japan conducted study of roxadustat, an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia in chronic...
